首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于中药整合药理学平台分析黄连汤治疗胃炎的作用机制
引用本文:吴智春,于华芸,张成博,马婷,宗鑫,季旭明.基于中药整合药理学平台分析黄连汤治疗胃炎的作用机制[J].中国实验方剂学杂志,2019,25(4):57-62.
作者姓名:吴智春  于华芸  张成博  马婷  宗鑫  季旭明
作者单位:山东中医药大学, 济南 250355,山东中医药大学, 济南 250355,山东中医药大学, 济南 250355,山东中医药大学, 济南 250355,山东中医药大学, 济南 250355,山东中医药大学, 济南 250355;浙江中医药大学, 杭州 310053
基金项目:山东省重点产业关键技术项目(2016CYJS08A01-4,2016CYJS08A01-3);山东省重点研发计划项目(2016ZDJS07A12)
摘    要:目的:探讨黄连汤治疗胃炎的功效物质基础和可能的作用机制,为该复方的后续应用与研发提供参考。方法:利用中药整合药理学平台预测黄连汤治疗胃炎的主要活性成分和作用靶点,构建黄连汤成分靶标-疾病靶标网络,筛选关键节点进行通路富集分析,探索黄连汤多成分-多靶点-多通路治疗胃炎的可能作用机制。结果:黄连汤预测的175个活性成分与胃炎相关的538个关键靶标相互作用,通过趋化因子、雌激素和T细胞受体等信号通路参与幽门螺旋杆菌感染侵润、胃黏膜损伤、胃黏膜萎缩等胃炎发生与发展过程中病理环节的调控。结论:该研究初步揭示了黄连汤治疗胃炎的潜在活性成分及其可能的作用机制,为该方进一步的药效物质基础和作用机制实验研究提供了理论依据。

关 键 词:黄连汤  整合药理学  胃炎  作用机制  靶点  通路分析  相互作用网络
收稿时间:2018/3/7 0:00:00

Analysis of Molecular Mechanism of Huangliantang in Treatment of Gastritis Based on Integrated Pharmacology Platform of Traditional Chinese Medicine
WU Zhi-chun,YU Hua-yun,ZHANG Cheng-bo,MA Ting,ZONG Xin and JI Xu-ming.Analysis of Molecular Mechanism of Huangliantang in Treatment of Gastritis Based on Integrated Pharmacology Platform of Traditional Chinese Medicine[J].China Journal of Experimental Traditional Medical Formulae,2019,25(4):57-62.
Authors:WU Zhi-chun  YU Hua-yun  ZHANG Cheng-bo  MA Ting  ZONG Xin and JI Xu-ming
Institution:Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China and Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China;Zhejiang Chinese Medical University, Hangzhou 310053, China
Abstract:Objective: To investigate the effective substance basis and possible mechanism of Huangliantang in treatment of gastritis. Method: Integrated pharmacology platform of traditional Chinese medicine was employed to predict the main active ingredients and functional targets of Huangliantang in treatment of gastritis, network of composition target-disease target of Huangliantang was constructed, key nodes were screened for enrichment analysis of pathways, and the possible mechanism of Huangliantang in treatment of gastritis with multiple ingredients-multiple targets-multiple pathways was explored. Result: A total of 175 predicted active ingredients of Huangliantang interacted with 538 key targets about gastritis, the regulation and treatment of gastritis during its different pathological stages, such as Helicobacter pylori infection, gastric mucosal damage and gastric mucosal atrophy, were involved through chemokine, T cell receptor, estrogen and other signaling pathways. Conclusion: This research may reveal the potential active ingredients of Huangliantang in treatment of gastritis and its possible mechanism, and it also provides a theoretical basis for further experimental research of pharmacodynamic substance basis and mechanism of action.
Keywords:Huangliantang  integrated pharmacology  gastritis  mechanism of action  targets  pathway analysis  interaction network
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号